| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 2072901-32-5 | Rovanersen(WVE-120101) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 629167-92-6 | Mipomersen sodium |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 160369-77-7 | Fomivirsen sodium |
≥98% | | 询价 |
| 4 | 77353-69-6 | N-Demethylansamitocin P-3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 178603-78-6 | Ac-YVAD-CMK |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 985-16-0 | Nafcillin Sodium |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 7 | 98769-81-4 | Reboxetine mesylate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 118343-19-4 | BRL-44408 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 941580-60-5 | NVS-PI3-4 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 86694-45-3 | preQ-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 1646267-59-5 | ACT-660602 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 1399849-02-5 | SPH-3127(DRI-18) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 1997321-20-6 | GNE-064 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 1574576-45-6 | P163-0892 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | 2410534-62-0 | DC-U4106 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 2719793-91-4 | (R)-RP-6306 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 2719749-28-5 | (Rac)-RP-6306 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | | MS-159 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 19 | | (D-Trp11)-Neurotensin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 20 | | (Trp11)-Neurotensin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 55508-42-4 | Neurotensin |
≥98% | | 询价 |
| 22 | | (Gly1,Ser3·22,Gln4·34,Thr6,Arg19,Tyr21,Ala23·31,Aib32)-Pancreatic Polypeptide(human) |
≥98% | | 询价 |
| 23 | 168916-68-5 | (His32,Leu34)-Neuropeptide Y(32-36) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | 161650-01-7 | (Pro30,Tyr32,Leu34)-Neuropeptide Y(28-36) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 25 | 172997-92-1 | ((Cys31,Nva34)-Neuropeptide Y(27-36))2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 26 | 163887-48-7 | (D-Tyr27·36,D-Thr32)-Neuropeptide Y(27-36) |
≥98% | | 询价 |
| 27 | 185032-24-0 | Tyr-Lys-Gly-(Cyclo(Glu26-Lys29),Pro34)-Neuropeptide Y(25-36) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | 155709-24-3 | Acetyl-(Leu28·31)-Neuropeptide Y(24-36) |
≥98% | | 询价 |
| 29 | 313988-70-4 | Pancreatic Polypeptide(1-17)-(Ala31,Aib32)-Neuropeptide Y(18-36)(human) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | 114495-97-5 | Neuropeptide Y(18-36) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | 113662-54-7 | Neuropeptide Y(13-36)(porcine) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 302798-54-5 | (Leu31,Pro34)-Neuropeptide Y(13-36)(human,rat) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | 143863-88-1 | Neuropeptide Y(3-36)(porcine) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 150138-78-6 | Neuropeptide Y(3-36)(human,rat) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 102961-52-4 | Neuropeptide Y(2-36)(porcine) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 123139-39-9 | Neuropeptide Y(2-36)(human,rat) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | 128806-04-2 | (Cys2)-Neuropeptide Y(1-4)-8-aminooctanoyl-(D-Cys27)-Neuropeptide Y(25-32)|C2-NPY |
≥98% | | 询价 |
| 38 | 131448-51-6 | Neuropeptide Y(1-24)amide(human,rat) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 153549-78-1 | (D-Trp32)-Neuropeptide Y(porcine) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 40 | 128768-54-7 | (Pro34)-Neuropeptide Y(porcine) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 125580-28-1 | (Leu31,Pro34)-Neuropeptide Y(porcine) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 42 | 313988-59-9 | (Ala31,Aib32)-Neuropeptide Y(porcine) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 43 | 139026-64-5 | (Lys8,Lys9)-Neurotensin(8-13) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | | (Dab9)-Neurotensin(8-13) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 45 | 74853-69-3 | Acetyl-Neurotensin(8-13) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 74032-89-6 | Neurotensin(1-11) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 80887-44-1 | Neurotensin(1-8) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | 64088-62-6 | (D-Tyr11)-Neurotensin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 49 | 201852-69-9 | H-Gly-Ala-AMC·HCl |
≥98% | | 询价 |
| 50 | 31461-61-7 | H-Glu-Val-Phe-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | 314266-76-7 | H-Glu-Val-Asn-[(2R,4S,5S)-5-amino-4-hydroxy-2,7-dimethyl-octanoyl]-Ala-Glu-Phe-OH |
≥98% | | 询价 |
| 52 | 32140-46-8 | H-Glu-Tyr-Glu-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 53 | 110642-78-9 | H-Glu-Thr-Tyr-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 54 | 180387-75-1 | AMYLOIDPCOMPONENT(27-38)AMIDE |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | 42155-93-1 | H-Glu-Gly-Phe-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | 1948-29-4 | H-Glu-Gly-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | 23684-48-2 | H-Glu-Glu-Glu-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | 130778-96-0 | H-Glu-Glu-Asp-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | 3918-84-1 | H-Glu-Asp-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 60 | 148851-08-5 | H-Glu-Asn-Asp-Tyr(PO3H2)-Ile-Asn-Ala-Ser-Leu-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
m.cnreagent.com